Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)
Clinical trial NCT03131648 · COMPLETED
Trial details
- NCT number
- NCT03131648
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-30
- Primary completion
- 2018-08-07
- Enrollment
- 802
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.